药明康德: 无锡药明康德新药开发股份有限公司董事和高级管理人员所持公司股份及其变动管理办法(2025年修订)
Zheng Quan Zhi Xing·2025-09-02 10:25

Core Viewpoint - The document outlines the management measures for the shares held by directors and senior management of Wuxi AppTec Co., Ltd., emphasizing compliance with relevant laws and regulations to maintain market order and transparency in share transactions [1][2]. Summary by Sections General Principles - The management measures are established to strengthen the oversight of shares held by directors and senior management, ensuring adherence to the Company Law, Securities Law, and various regulatory guidelines [1]. - The measures apply to all shares held by directors and senior management, including those held in multiple accounts [2]. Trading Prohibitions and Restrictions - Directors and senior management are prohibited from transferring shares under specific circumstances, such as within one year of the company's stock listing or within six months after leaving the company [5]. - There are also restrictions on trading during certain periods, such as before the announcement of annual or quarterly reports [6][7]. Information Reporting and Disclosure - Directors and senior management must report their shareholdings and any changes to the board secretary promptly, ensuring accurate and timely disclosures [5][6]. - Any share reduction plans must be reported in advance, detailing the number of shares, method, and reasons for the reduction [6][10]. Violations and Responsibilities - The company can impose penalties on directors and senior management for violations of these measures, including financial penalties and potential legal action [11][12]. - The board secretary is responsible for managing and monitoring the shareholding data of directors and senior management [10][12]. Additional Provisions - Shareholders holding more than 5% of the company's shares are also subject to similar reporting and trading restrictions [11]. - The measures will take effect upon approval by the board and will supersede previous regulations [12].